Avai Bio (AVAI) Payables (2018 - 2025)

Avai Bio has disclosed Payables across 8 years of filings, most recently posting $1.7 million for Q4 2025.

• Payables for Q4 2025 came in at $1.7 million, down 2.83% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.7 million (down 2.83% YoY), and the FY2025 annual result was $1.3 million, up 8.11% from the prior year.
• Payables came in at $1.7 million for Q4 2025 at Avai Bio, up from $1.3 million in the prior quarter.
• In the past five years, Payables ranged from a high of $1.8 million in Q4 2024 to a low of $166721.0 in Q3 2022.
• The 5-year median for Payables is $961514.0 (2021), against an average of $864181.0.
• Across the five-year window, Payables surged 905.41% in 2021 and plunged 82.14% in 2022, its largest moves.
• Avai Bio's Payables stood at $186073.0 in 2021, then soared by 37.85% to $256501.0 in 2022, then soared by 346.59% to $1.1 million in 2023, then soared by 54.46% to $1.8 million in 2024, then dropped by 2.83% to $1.7 million in 2025.
• The last three Payables figures came in at $1.7 million (Q4 2025), $1.3 million (Q3 2025), and $1.4 million (Q2 2025), per Business Quant data.